Candel Therapeutics Inc. Made Headway
Wed, Dec 11, 2024 at 07:06 PM
Candel Therapeutics Inc. (CADL:NASDAQ) soared at $7.75, representing a gain of 68.1%. On Wed, Dec 11, 2024, CADL:NASDAQ touched a New 2-Week High of $7.75. The stock got featured on our News Catalysts scanner on Wed, Dec 11, 2024 at 04:43 PM in the 'BIOTECH' category. From Wed, Nov 27, 2024, the stock recorded 33.33% Up Days and 30.00% Green Days
The stock spiked on Wed, Dec 11, 2024 at $14.6 with a volume of 100M+.
About Candel Therapeutics Inc. (CADL:NASDAQ)
Candel Therapeutics Inc is a late clinical stage biopharmaceutical company. It is focused on helping patients fight cancer with oncolytic viral immunotherapies.
Top 10 Gainers:
- MSP Recovery Inc. (LIFW:NASDAQ), 103.77%
- SEALSQ Corp. (LAES:NASDAQ), 101.4%
- Candel Therapeutics Inc. (CADL:NASDAQ), 68.11%
- Jiuzi Holdings Inc. (JZXN:NASDAQ), 63.39%
- Leddartech Hldgs Inc Com (LDTC:NASDAQ), 49.59%
- OS Therapies Incorporated (OSTX:NYSEMKT), 46.8%
- AEON Biopharma Inc. Class A (AEON:NYSEMKT), 46.1%
- Stitch Fix, Inc. (SFIX:NASDAQ), 44.35%
- Syntec Optics Holdings Inc Cl A (OPTX:NASDAQ), 43.01%
- Mitcham Industries, Inc. (MIND:NASDAQ), 42.32%